Saving lives through technology
We want our AI technology to
not only perform in the highest level,
but also to serve for ‘the right’ purposes.
For us, this is ‘saving more lives.’
We aim to solve the most critical issues
in cancer care today:
reduce medical cost and prolong survival.
As a company, our philosophy is
to follow value over profit.
Our eyes are fixed in the fundamental
and inherent values,
while we simply take a portion
of the fruit we bear.
Our Vision
Perfecting Intelligence,
Transforming Medicine.
Lunit, a portmanteau of ‘Learning unit,’ is a medical AI software company
devoted to providing AI-powered total cancer care.
Our AI solutions help discover cancer and predict cancer treatment outcomes,
achieving timely and individually-tailored cancer treatment.
Lunit Core Values
*Lunit AI researchers,
Seonwook Park and Thijs Kooi.
Be Original
We are not afraid to step apart from
the crowd and become different.
We value originality and try hard to uphold it.Motivate Yourself
The strongest drive for achievement
comes from within oneself.
We are passionate and self-driven.Live to Learn
Growth excites us. It is in our DNA.
We are people who enjoy learning and
there is nothing we can’t learn.Build with Evidence
Ideas can come from intuitions,
but the journey in making ideas into
reality is built with robust evidence.Push for Craftsmanship
We pursue craftsmanship to achieve
perfection and maintain high credibility.
We create an impact and make changes.Love One Another
We value and appreciate the people
we work with, and this is how we put ourselves in others' shoes and think for
ways to help them.
Leadership Principles
- Heart of a World Champion
- A champion pushes for excellence. A champion rises to the top. A champion is bold and courageous. Leading with the heart of a world champion means all of the above, added with a global mindset. As a company that provides medical solutions, we believe our solutions are inherently universal, impacting all human beings around the globe. Leaders at Lunit never cease to keep that perspective.
Our Journey
A First Generation
Medical AI Start-up
History
2020
- Recommended by the World Health Organization (WHO) as a diagnostic tool to replace medical professionals in tuberculosis screenings
- Raised $26M (Series C, Tranche B)
- Raised $61M (Pre-IPO)
- PMDA approved <CXR-AID>, a collaboration between Fujifilm and Lunit, in Japan
- FDA cleared <Lunit INSIGHT MMG>
- FDA cleared <Lunit INSIGHT CXR Triage>
- First showcase for <Lunit INSIGHT Chest CT>, <Lunit INSIGHT DBT>
- ‘Digital Health 150’ by CB Insights
- Raised $26M (Series C, Tranche A)
- Europe CE certified, <Lunit INSIGHT MMG>
- Awarded by World Economic Forum as one of 100 “Technology Pioneer 2020”
- Digital Health 150, by CB Insights
- Ministry of Korea Food and Drug Safety clearance, <Lunit INSIGHT MMG>
- Europe CE marked, <Lunit INSIGHT CXR>
- 1st place in <Visual Domain Adaptation Challenge>
- Raised $15M (Series B)
- Ministry of Korea Food and Drug Safety clearance, <Lunit INSIGHT CXR-Nodule>
- Launched its second product, <Lunit INSIGHT MMG>
- Top 100 AI startup, by CB Insights
- Top 5 “Social Impact” AI startup, by NVIDIA
- Ranked 1st place in <CAMELYON Grand Challenge 2017>
- 5th place in <The Digital Mammography DREAM Challenge 2017>
- Launched its first product, <Lunit INSIGHT CXR-Nodule>
- Raised $3.5M (Series A)
- 1st place in MICCAI Tumor Proliferation Assessment Challenge 2016
Fundraising
History
Series
Closing Date
Investment
Lead Investor
Other Investor
SeriesSeed
Closing Date2014. 05
Investment$0.1M
Lead InvestorKakao Ventures
Other Investor-
SeriesSeries A
Closing Date2015. 10
Investment$2M
Lead InvestorSoftbank Ventures Asia(Korea/Japan)
Other InvestorKakao Ventures, Formation 8 (USA)
SeriesSeries A1
Closing Date2016. 09
Investment$3.3M
Lead InvestorSoftbank Ventures Asia
Other InvestorKakao Ventures, Mirae Asset Venture Investment, Intervest
SeriesSeries B
Closing Date2018. 06
Investment$15M
Lead InvestorIntervest
Other InvestorSoftbank Ventures Asia, Kakao Ventures, Mirae Asset Venture Investment, Intervest, KT Investment, Legend Capital (China)
SeriesSeries B1
Closing Date2019. 08
Investment$5M
Lead InvestorFujiFilm (Japan)
Other InvestorLegend Capital
SeriesSeries C (Tranche A)
Closing Date2019. 12
Investment$27M
Lead InvestorShinhan Investment
Other InvestorKakao Ventures, Intervest, IMM Investment, Legend Capital, LG CNS, NH Investment&Securities
SeriesSeries C (Tranche B)
Closing Date2021.07
Investment$26M
Lead InvestorGuardant Health (USA)
Other Investor-
SeriesPre-IPO (Tranche A)
Closing Date2021.11
Investment$22M
Lead InvestorNaver
Other InvestorKakao Ventures, Softbank Ventures Asia, IMM Investment, Mirae Asset Venture Investment, Naver Cloud
SeriesPre-IPO (Tranche B)
Closing Date2021.11
Investment$39M
Lead InvestorHealthQuest Capital (USA)
Other InvestorTybourne Capital (USA), Legend Capital, Casdin Capital (USA), BrightEdge (USA), NSG Ventures (SGP)
SeriesSeed
Closing Date2014. 05
Investment$0.1M
Lead InvestorKakao Ventures
Other Investor-
SeriesSeries A
Closing Date2015. 10
Investment$2M
Lead InvestorSoftbank Ventures Asia(Korea/Japan)
Other InvestorKakao Ventures, Formation 8 (USA)
SeriesSeries A1
Closing Date2016. 09
Investment$3.3M
Lead InvestorSoftbank Ventures Asia
Other InvestorKakao Ventures, Mirae Asset Venture Investment, Intervest
SeriesSeries B
Closing Date2018. 06
Investment$15M
Lead InvestorIntervest
Other InvestorSoftbank Ventures Asia, Kakao Ventures, Mirae Asset Venture Investment, Intervest, KT Investment, Legend Capital (China)
SeriesSeries B1
Closing Date2019. 08
Investment$5M
Lead InvestorFujiFilm (Japan)
Other InvestorLegend Capital
SeriesSeries C (Tranche A)
Closing Date2019. 12
Investment$27M
Lead InvestorShinhan Investment
Other InvestorKakao Ventures, Intervest, IMM Investment, Legend Capital, LG CNS, NH Investment&Securities
SeriesSeries C (Tranche B)
Closing Date2021.07
Investment$26M
Lead InvestorGuardant Health (USA)
Other Investor-
SeriesPre-IPO (Tranche A)
Closing Date2021.11
Investment$22M
Lead InvestorNaver
Other InvestorKakao Ventures, Softbank Ventures Asia, IMM Investment, Mirae Asset Venture Investment, Naver Cloud
SeriesPre-IPO (Tranche B)
Closing Date2021.11
Investment$39M
Lead InvestorHealthQuest Capital (USA)
Other InvestorTybourne Capital (USA), Legend Capital, Casdin Capital (USA), BrightEdge (USA), NSG Ventures (SGP)
Our Investors
Watch and learn more about Lunit
Lunit YouTube